scholarly journals Suicide gene therapy of sarcoma cell lines using recombinant adeno-associated virus 2 vectors

2004 ◽  
Vol 11 (8) ◽  
pp. 577-584 ◽  
Author(s):  
Marlon R Veldwijk ◽  
Simone Berlinghoff ◽  
Stephanie Laufs ◽  
Ulrich R Hengge ◽  
W Jens Zeller ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Cell Lines ◽  
Suicide Gene ◽  
Suicide Gene Therapy ◽  
Sarcoma Cell ◽  
Adeno Associated Virus

Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy

Lung Cancer ◽  
2004 ◽  
Vol 46 (2) ◽  
pp. 179-186 ◽  
Author(s):  
Simone Berlinghoff ◽  
Marlon R. Veldwijk ◽  
Stephanie Laufs ◽  
Hans-Peter Maser ◽  
Anna Jauch ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Cell Lines ◽  
Suicide Gene ◽  
Suicide Gene Therapy ◽  
Adeno Associated Virus ◽  
Mesothelioma Cell

scholarly journals Safety and Efficacy of Suicide Gene Therapy with Adenosine Deaminase 5-Fluorocytosine Silmutaneously in in Vitro Cultures of Melanoma and Retinal Cell Lines

2014 ◽  
Vol 5 (5) ◽  
pp. 368-381 ◽  
Author(s):  
Antonios Sakkas ◽  
Paul Zarogoulidis ◽  
Kalliopi Domvri ◽  
Wolfgang Hohenforst-Schmidt ◽  
Dimitris Bougiouklis ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Adenosine Deaminase ◽  
Cell Lines ◽  
Suicide Gene ◽  
In Vitro Cultures ◽  
Suicide Gene Therapy ◽  
Retinal Cell ◽  
Safety And Efficacy

Suicide gene therapy for brain tumor by means of adeno-associated virus (AAV) vector

1997 ◽  
Vol 99 ◽  
pp. S5
Author(s):  
Jun Yoshida ◽  
Masaaki Mizuno ◽  
Hideho Okada ◽  
Toshihiko Wakabayashi
Keyword(s):  
Gene Therapy ◽  
Brain Tumor ◽  
Suicide Gene ◽  
Suicide Gene Therapy ◽  
Aav Vector ◽  
Adeno Associated Virus

Characterization of Human Mesothelioma Cell Lines as Tumor Models for Suicide Gene Therapy

Onkologie ◽  
2008 ◽  
Vol 31 (3) ◽  
pp. 91-96 ◽  
Author(s):  
Marlon R. Veldwijk ◽  
Simone Berlinghoff ◽  
Anna Jauch ◽  
Stephanie Laufs ◽  
Jens Zeller ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Cell Lines ◽  
Suicide Gene ◽  
Suicide Gene Therapy ◽  
Tumor Models ◽  
Mesothelioma Cell

Cyclooxygenese-2 promoter can mittigate the lethal toxicity in HSV-TK based adenoviral suicide gene therapy of gastrointestinal cancers

2001 ◽  
Vol 120 (5) ◽  
pp. A10-A10
Author(s):  
M YAMAMOTO ◽  
R ALEMANY ◽  
Y ADACHI ◽  
W GRIZZLE ◽  
D CURIEL
Keyword(s):  
Gene Therapy ◽  
Suicide Gene ◽  
Suicide Gene Therapy ◽  
Gastrointestinal Cancers ◽  
Lethal Toxicity

Nanoparticle‐Mediated Suicide Gene Therapy for Triple Negative Breast Cancer Treatment

2020 ◽  
Vol 3 (8) ◽  
pp. 2000007
Author(s):  
Lucia Salvioni ◽  
Stefania Zuppone ◽  
Francesco Andreata ◽  
Matteo Monieri ◽  
Serena Mazzucchelli ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Gene Therapy ◽  
Cancer Treatment ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Suicide Gene ◽  
Breast Cancer Treatment ◽  
Suicide Gene Therapy

scholarly journals Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma

Pharmaceutics ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 202
Author(s):  
Anna Egorova ◽  
Sofia Shtykalova ◽  
Alexander Selutin ◽  
Natalia Shved ◽  
Marianna Maretina ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Uterine Leiomyoma ◽  
Transfection Efficiency ◽  
Chemical Properties ◽  
Suicide Gene ◽  
Suicide Gene Therapy ◽  
Benign Tumors ◽  
Αvβ3 Integrin ◽  
Peptide Carrier ◽  
Plasmid Delivery

Uterine leiomyoma (UL) is one of the most common benign tumors in women that often leads to many reproductive complications. Suicide genetherapy was suggested as a promising approach for UL treatment. In the present study, we describe iRGD ligand-conjugated cysteine-rich peptide carrier RGD1-R6 for targeted DNA delivery to αvβ3 integrin-expressing primary UL cells. The physico-chemical properties, cytotoxicity, transfection efficiency and specificity of DNA/RGD1-R6 polyplexes were investigated. TheHSV-1thymidine kinase encoding plasmid delivery to PANC-1pancreatic carcinoma cells and primary UL cells resulted in significant suicide gene therapy effects. Subsequent ganciclovir treatment decreased cells proliferative activity, induced of apoptosis and promoted cells death.The obtained results allow us to concludethatthe developed RGD1-R6 carrier can be considered a promising candidate for suicide gene therapy of uterine leiomyoma.

Sign in / Sign up

Export Citation Format

Share Document